1. Home
  2. CTSO vs CSTE Comparison

CTSO vs CSTE Comparison

Compare CTSO & CSTE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CTSO
  • CSTE
  • Stock Information
  • Founded
  • CTSO 1997
  • CSTE 1987
  • Country
  • CTSO United States
  • CSTE Israel
  • Employees
  • CTSO N/A
  • CSTE N/A
  • Industry
  • CTSO Medical/Dental Instruments
  • CSTE Building Materials
  • Sector
  • CTSO Health Care
  • CSTE Industrials
  • Exchange
  • CTSO Nasdaq
  • CSTE Nasdaq
  • Market Cap
  • CTSO 58.6M
  • CSTE 61.9M
  • IPO Year
  • CTSO N/A
  • CSTE 2012
  • Fundamental
  • Price
  • CTSO $0.92
  • CSTE $1.51
  • Analyst Decision
  • CTSO Buy
  • CSTE
  • Analyst Count
  • CTSO 2
  • CSTE 0
  • Target Price
  • CTSO $5.50
  • CSTE N/A
  • AVG Volume (30 Days)
  • CTSO 78.2K
  • CSTE 62.9K
  • Earning Date
  • CTSO 11-06-2025
  • CSTE 11-12-2025
  • Dividend Yield
  • CTSO N/A
  • CSTE N/A
  • EPS Growth
  • CTSO N/A
  • CSTE N/A
  • EPS
  • CTSO N/A
  • CSTE N/A
  • Revenue
  • CTSO $36,107,520.00
  • CSTE $406,178,000.00
  • Revenue This Year
  • CTSO $11.93
  • CSTE N/A
  • Revenue Next Year
  • CTSO $21.22
  • CSTE $5.61
  • P/E Ratio
  • CTSO N/A
  • CSTE N/A
  • Revenue Growth
  • CTSO 20.18
  • CSTE N/A
  • 52 Week Low
  • CTSO $0.71
  • CSTE $1.35
  • 52 Week High
  • CTSO $1.61
  • CSTE $5.04
  • Technical
  • Relative Strength Index (RSI)
  • CTSO 45.35
  • CSTE 47.40
  • Support Level
  • CTSO $0.90
  • CSTE $1.51
  • Resistance Level
  • CTSO $0.96
  • CSTE $1.63
  • Average True Range (ATR)
  • CTSO 0.05
  • CSTE 0.10
  • MACD
  • CTSO -0.00
  • CSTE 0.00
  • Stochastic Oscillator
  • CTSO 16.67
  • CSTE 25.64

About CTSO Cytosorbents Corporation

CytoSorbents Corp specializes in treating life-threatening conditions in intensive care and cardiac surgery using proprietary polymer adsorption technology. Its flagship product, CytoSorb, is approved in the EU as an extracorporeal cytokine absorber, aiming to reduce inflammation and prevent multiple organ failure in critical illnesses like sepsis and trauma. Revenue primarily comes from product sales in Germany, with additional income from grant agencies in the United States. The company operates through Direct sales and Distributors/strategic partners in United States, Germany and Other Countries. The company's product consists of Cytosorb, ECOS-300CY, VetResQ, HemoDefend, and DrugSorb-ATR.

About CSTE Caesarstone Ltd.

Caesarstone Ltd manufactures engineered quartz surfaces. Its products include engineered quartz and porcelain slabs, which are used as kitchen countertops in renovation and remodeling, and residential construction. It also has other applications, including vanity tops, wall panels, backsplashes, floor tiles, stairs, and other interior surfaces that are used in various residential and non-residential applications. The company sells its products under the Caesarstone brand. Caesarstone's geographical segments are the United States, Canada, Latin America, Australia, Asia, Israel, and EMEA(Europe, Middle East, Africa).

Share on Social Networks: